Compare Palantir Technologies Inc (PLTR) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Palantir Technologies Inc vs uniQure N.V. Ordinary Shares — how do they compare? Palantir Technologies Inc trades at $197.93 (market cap $501.45B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Palantir Technologies Inc is far larger — about 338.8× uniQure N.V. Ordinary Shares's market cap, and Palantir Technologies Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Palantir Technologies Inc for 79 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| PLTR | QURE | |
|---|---|---|
Market Cap | $501.45B | $1.48B |
Volume | 18,438,992 | 2,488,780 |
Sector | Technology | Health |
52-Week High | $209.05 | $70.59 |
52-Week Low | $107.27 | $9.03 |
Typical Hold Time | 79 Days | 0 Days |
Enterprise Value | $492.25B | $728.62M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Palantir (PLTR) trades at $200.97, down 3.84% on the day but maintains strong bullish technical momentum with consecutive earnings beats. The company demonstrates exceptional fundamental performance with 56.2% revenue growth in 2025, reaching $4.48 billion, and net income margin expanding to 36.3%. Recent partnership with Armada for sovereign AI infrastructure and consistent analyst optimism highlight the stock's growth trajectory despite premium valuation metrics.
Outlook remains positive with accelerating AI adoption driving growth, though elevated P/E of 178.35 presents valuation risk. Wall Street consensus targets $195.86 with 54% buy ratings, while technical indicators show potential resistance near $213-$219 levels. Key risks include growth normalization and competitive pressures in the expanding AI software market.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
